Quick Summary
Additional Context
Materialise (Euronext Brussels & Nasdaq: MTLS) is seeing continued growth in its medical 3D printing business and signs of a recovery in manufacturing, but that progress has not been enough to prevent a decline in profits. The Belgian company reported higher third-quarter revenue, driven by demand for its medical products and growing business in aerospace and defense. However, higher costs and weaker software sales hurt profits, although the company kept its financial forecast for the full year unchanged.
For the third quarter of 2026, Materialise reported revenue of €67.7 million ($75.6 million), up 2.1% from €66.3 million ($74 million) a year earlier. But the company recently sold two businesses, RapidFit and Eyewear, so their sales no longer contribute to its revenue. Excluding the sal